shrna library (Broad Institute Inc)
Structured Review

Shrna Library, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/shrna library/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1 -based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype"
Article Title: Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1 -based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype
Journal: Cell Death & Disease
doi: 10.1038/s41419-025-07855-y
Figure Legend Snippet: A Immunoblotting of PAI-1 in HCT116-MD and HD knocked down for the protein using two unique shRNAs (sh3 and sh5). B Fold change of PAI-1 protein in cell culture supernatant of HCT116-MD and HD knocked down for the protein relative to MD shRNA control (shCtrl). C Oxaliplatin IC 50 fold change HCT116-MD and HD knocked down for the protein relative to MD shCtrl. Representative dose response curves of HCT116-MD shCtrl, PAI-1 sh3 and sh5 ( D ) and HCT116-HD shCtrl, PAI-1 sh3 and sh5 ( E ). F Three representative H&E staining for spontaneous metastasis in lung sections of mice harboring HCT116-PAR xenografts treated with oxaliplatin alone, or in combination with PAI-1 inhibitor, tiplaxtinin (20 mg/kg). F’ Quantification of tumor nodules area in lung sections of mice harboring HCT116-PAR xenografts treated with oxaliplatin alone, or in combination with tiplaxtinin (20 mg/kg). Statistical significance was determined using Ordinary one-way ANOVA followed by Sidak’s multiple comparisons test for ( B , C ) and two-tailed unpaired t -test for ( F’ ).
Techniques Used: Western Blot, Cell Culture, shRNA, Control, Staining, Two Tailed Test

![Complex I function mediated by NDUFV1 is important for cell cycle progression in cancer cells. (A) Western blotting with the indicated antibodies in MDA‐MB‐231 cells after 48 h of treatment with siRNAs for the major catalytic subunits of the electron transport chain complexes (I, NDUFV1 ; II, SDHA ; III, UQCRFS1 ; IV, SURF1 ). Ctr, negative <t>control</t> <t>siRNA.</t> α‐Tubulin is the loading control. Silencing efficiency of each siRNA was evaluated based on the band intensity quantified by imagej software, which was normalized to that of α‐tubulin and shown relative to Ctr. Representative results from three independent experiments are shown. (B, C) Cell proliferation and viability (B, MDA‐MB‐231 and MCF7; C, JHH‐4 and HLF) after transfection with the indicated siRNAs for 72 h: NDU, NDUFV1 . Silencing efficiencies of siRNAs are indicated in Table . (D, E) Doxycycline (DOX)‐responsive (TetOFF) <t>shRNA</t> [NDU (NDFUV1) or NT (nontarget control) (Table )]‐expressing cells were obtained from MCF7 cells by lentiviral transduction of the constructs (Materials and methods). Cells were incubated for 48 h in the presence (+) or absence (−) of DOX (1.0 μg·mL −1 ) and NDUFV1 knockdown was validated by western blotting. Representative blots from three independent experiments are shown (D). Growth curve and doubling time. 2 × 10 4 cells were seeded in the presence or absence of DOX; the number of viable cells was counted on each culture day. Doubling time (DT) was calculated from the slope of the graph (E). (F) Cell cycle distribution of siRNA‐transfected MCF7 and MDA‐MB‐231 cells. Bars and plots represent the means ± standard deviation from three independent experiments with measurements in triplicate in each experiment. For statistical analysis, two‐tailed Student's t ‐test (C and F) and one‐way ANOVA Dunnett's multiple comparisons test among group (B and E) were used; ** P < 0.01.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1471/pmc12161471/pmc12161471__MOL2-19-1775-g007.jpg)